About Idan Elmelech
Idan Elmelech is COO & Principal Financial Ofcr at BridgeBio Oncology Therapeutics.
Form D filings name Idan Elmelech as an executive officer at TheRas.
Idan Elmelech reports to the SEC as an officer of 1 public company.
Idan Elmelech first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Idan Elmelech in the role, so the role may have started earlier or lasted longer.
BI
BridgeBio Oncology Therapeutics, Inc.
COO & Principal Financial Ofcr
2026 · Public company (BBOT)
Key Colleagues at Startups
The people Idan Elmelech works with at each company, as listed on that company's latest Form D.
TheRas, Inc. · Form D, May 15, 2024
MD
Michelle Doig
Director
PB
Pedro Beltran
Executive officer
FM
Frank McCormick
Director
NK
Neil Kumar
Director
EW
Eli Wallace
CEO
RK
Raymond Kelleher
Director